For Immediate Release
Chicago, IL – May 8, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Berkshire Hathaway BRK.B, Merck MRK, Charter Communications CHTR, Anthem ANTM and Norfolk Southern NSC.
Here are highlights from Tuesday’s Analyst Blog:
Top Analyst Reports for Berkshire Hathaway, Merck and Charter Communications
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway, Merck and Charter Communications. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Berkshire Hathaway’s shares have underperformed the Zacks Insurance - Property and Casualty industry year to date (+4.4% vs. +6.4%). Berkshire Hathaway’s first-quarter operating earnings increased 5% year over year on solid results across all segments. The Zacks analyst thinks the company is poised for growth over the long term on its sturdy insurance business.
The company’s inorganic growth story remains impressive with strategic acquisitions. A strong cash position allows it to make earnings-accretive bolt-on buyouts. Demand for utilities is expected to rise in the future and drive earnings growth. Continued insurance business growth also fuels increase in float. A sturdy capital level provides further impetus.
However, exposure to catastrophe loss remains a concern as its property and casualty insurance business generates maximum return on equity. Also, huge capital expenses due to railroad operations pose concerns. Capital expenditure is estimated to be $10.5 billion in 2019.
Shares of Buy-ranked Merck have increased +4% year to date, outperforming the Zacks Large Cap Pharmaceuticals industry’s gain of +0.5% during the same period. Merck beat estimates for both earnings and sales in the first quarter. The Zacks analyst thinks Merck’s new products like Keytruda, Lynparza and Bridion are contributing meaningfully to the top line. Keytruda sales are gaining momentum with approval for additional indications, especially in the first-line lung cancer setting.
Keytruda has strong growth prospects based on increased utilization, recent approvals for new indications and potential additional approvals worldwide. Animal health and vaccine products are also performing strongly and remain core growth drivers for Merck.
However, generic competition for several drugs and pricing pressure will continue to be overhangs on the top line. Rising competitive pressure on the diabetes franchise and products like Isentress (HIV), Zepatier (HCV) and Zostavax (vaccine) remains a concern.
Charter Communications’ shares have outperformed the Zacks Cable TV industry year to date (+32% vs. +26.4%).Charter’s first-quarter 2019 earnings and revenues grew year over year. The company’s top line benefited from growth in Internet, video, mobile and commercial revenues. Increase in Internet subscribers coupled with more users moving to higher speed tiers aided Internet revenues.
The Zacks analyst likes the fact that Charter is looking to attract video customers by providing a new OTT video service. The company launched Spectrum TV Essentials in Charter’s footprint for Spectrum Internet users who do not avail Spectrum video services.
However, the company noted that its Internet penetration rate is about 50%, which is low when compared to its potential to deliver faster and cost-efficient services. Moreover, commercial revenue growth came below commercial customer relationship growth due to migration of customers to Spectrum pricing and packaging from Legacy TWC and Legacy Bright House.
Other noteworthy reports we are featuring today include Anthem and Norfolk Southern.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Norfolk Southern Corporation (NSC) : Free Stock Analysis Report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
Charter Communications, Inc. (CHTR) : Free Stock Analysis Report
Berkshire Hathaway Inc. (BRK.B) : Free Stock Analysis Report
Anthem, Inc. (ANTM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research